Please try another search
For the fiscal year ended 31 December 2021, Intrinsic Medicine Inc revenues was not reported. Net loss increased from $2M to $12M. Higher net loss reflects Change in fair value of financing deriva increase from $46K to $3.5M (expense), Change in fair value of future equity li increase from $457K to $2.8M (expense), General and administrative - Balancing v increase from $660K to $2.8M (expense).
Period Ending: | Dec 31, 2021 | Dec 31, 2020 |
---|---|---|
Total Revenue | 0 | 0 |
Gross Profit | ||
Operating Income | -3.47 | -1.2 |
Net Income | -11.95 | -1.99 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 |
---|---|---|
Total Assets | 3.76 | 0.85 |
Total Liabilities | 17.77 | 3.18 |
Total Equity | -14 | -2.33 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 |
---|---|---|
Period Length: | 12 Months | 12 Months |
Cash From Operating Activities | -3.04 | -0.87 |
Cash From Investing Activities | ||
Cash From Financing Activities | 5 | 1.57 |
Net Change in Cash | 1.95 | 0.7 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review